# Results of the phase III, placebo-controlled trial (SUCCEED) evaluating the mTOR inhibitor ridaforolimus (R) as maintenance therapy in advanced sarcoma patients (pts) following clinical benefit from prior standard cytotoxic chemotherapy (CT).

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/results-of-the-phase-iii-placebo-controlled-trial-succeed-evaluating-the-mtor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sant P. Chawla,Jean‐Yves Blay,I. L. Ray-Coquard,Axel Le Cesne,Arthur P. Staddon,Mohammed Milhem,Nicolas Penel,Richard F. Riedel,Binh Bui Nguyen,Lee D. Cranmer,Peter Reichardt,Emmanuelle Bompas,Yan Song,R. Lee,Joseph Eid,John W. Loewy,Frank G. Haluska,P. Dodion,G. D. Demetri |
| Citations | 77 |
| DOI | 10.1200/jco.2011.29.15_suppl.10005 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2209747046 |
| Type | conference-abstract |
| Year | 2011 |

## Paper authors

- [Yan Song](https://scholariq.org/researchers/yan-song/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)

## Paper topics

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Cardiac tumors and thrombi](https://scholariq.org/topics/cardiac-tumors-and-thrombi/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.